Price Alert

Fulgent Genetics Inc. (FLGT)

NASDAQ: FLGT · Real-Time Price · USD

22.09

0.14 (0.64%)

At close: Sep 08, 2025, 12:21 PM

Fulgent Genetics Statistics

Share Statistics

Fulgent Genetics has 30.61M shares outstanding. The number of shares has increased by 0.48% in one year.

Shares Outstanding	30.61M
Shares Change (YoY)	0.48%
Shares Change (QoQ)	-1.37%
Owned by Institutions (%)	52.83%
Shares Floating	19.73M
Failed to Deliver (FTD) Shares	53
FTD / Avg. Volume	0.02%

Short Selling Information

The latest short interest is 2.08M, so 6.75% of the outstanding shares have been sold short.

Short Interest	2.08M
Short % of Shares Out	6.75%
Short % of Float	12.29%
Short Ratio (days to cover)	5.01

Valuation Ratios

The PE ratio is -13.08 and the forward PE ratio is -33.3. Fulgent Genetics's PEG ratio is 0.17.

PE Ratio	-13.08
Forward PE	-33.3
PS Ratio	1.97
Forward PS	1.9
PB Ratio	0.49
P/FCF Ratio	-29
PEG Ratio	0.17

Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Fulgent Genetics.

EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.85, with a Debt / Equity ratio of 0.01.

Current Ratio	4.85
Quick Ratio	4.85
Debt / Equity	0.01
Debt / EBITDA	-0.19
Debt / FCF	-0.48
Interest Coverage	-434.81

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity	n/a
Return on Assets	n/a
Return on Invested Capital	n/a
Revenue Per Employee	$215.89K
Profits Per Employee	$-32.53K
Employee Count	1,313
Asset Turnover	0.23
Inventory Turnover	n/a

Taxes

Income Tax	-8.14M
Effective Tax Rate	15.66%

Stock Price Statistics

The stock price has increased by 2.52% in the last 52 weeks. The beta is 0.82, so Fulgent Genetics's price volatility has been higher than the market average.

Beta	0.82
52-Week Price Change	2.52%
50-Day Moving Average	20
200-Day Moving Average	18.77
Relative Strength Index (RSI)	62.66
Average Volume (20 Days)	267,603

Income Statement

In the last 12 months, Fulgent Genetics had revenue of 283.47M and earned -42.71M in profits. Earnings per share was -1.41.

Revenue	283.47M
Gross Profit	107.22M
Operating Income	-73.92M
Net Income	-42.71M
EBITDA	-48.99M
EBIT	-73.92M
Earnings Per Share (EPS)	-1.41

Full Income Statement

Balance Sheet

The company has 55.14M in cash and 9.23M in debt, giving a net cash position of 45.92M.

Cash & Cash Equivalents	55.14M
Total Debt	9.23M
Net Cash	45.92M
Retained Earnings	590.47M
Total Assets	1.2B
Working Capital	357.39M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 21.06M and capital expenditures -40.31M, giving a free cash flow of -19.25M.

Operating Cash Flow	21.06M
Capital Expenditures	-40.31M
Free Cash Flow	-19.25M
FCF Per Share	-0.64

Full Cash Flow Statement

Margins

Gross margin is 37.82%, with operating and profit margins of -26.08% and -15.07%.

Gross Margin	37.82%
Operating Margin	-26.08%
Pretax Margin	-18.33%
Profit Margin	-15.07%
EBITDA Margin	-17.28%
EBIT Margin	-26.08%
FCF Margin	-6.79%

Dividends & Yields

FLGT does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Analyst Forecast

The average price target for FLGT is $25, which is 13.9% higher than the current price. The consensus rating is "Buy".

Price Target	$25
Price Target Difference	13.9%
Analyst Consensus	Buy
Analyst Count	3

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Scores

Altman Z-Score	5.72
Piotroski F-Score	5